These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 32882582)

  • 1. Sarsasapogenin alleviates diabetic nephropathy through suppression of chronic inflammation by down-regulating PAR-1: In vivo and in vitro study.
    Tang ZZ; Zhang YM; Zheng T; Huang TT; Ma TF; Liu YW
    Phytomedicine; 2020 Nov; 78():153314. PubMed ID: 32882582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarsasapogenin ameliorates diabetes-associated memory impairment and neuroinflammation through down-regulation of PAR-1 receptor.
    Kong L; Liu Y; Zhang YM; Li Y; Gou LS; Ma TF; Liu YW
    Phytother Res; 2021 Jun; 35(6):3167-3180. PubMed ID: 33885189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
    Song W; Wei L; Du Y; Wang Y; Jiang S
    Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
    Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
    Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome.
    Ding T; Wang S; Zhang X; Zai W; Fan J; Chen W; Bian Q; Luan J; Shen Y; Zhang Y; Ju D; Mei X
    Phytomedicine; 2018 Mar; 41():45-53. PubMed ID: 29519318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of sarsasapogenin against early stage of diabetic nephropathy in rats.
    Liu YW; Hao YC; Chen YJ; Yin SY; Zhang MY; Kong L; Wang TY
    Phytother Res; 2018 Aug; 32(8):1574-1582. PubMed ID: 29682805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy.
    Yi H; Peng R; Zhang LY; Sun Y; Peng HM; Liu HD; Yu LJ; Li AL; Zhang YJ; Jiang WH; Zhang Z
    Cell Death Dis; 2017 Feb; 8(2):e2583. PubMed ID: 28151474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renoprotective effect of a novel combination of 6-gingerol and metformin in high-fat diet/streptozotocin-induced diabetic nephropathy in rats via targeting miRNA-146a, miRNA-223, TLR4/TRAF6/NLRP3 inflammasome pathway and HIF-1α.
    Aboismaiel MG; Amin MN; Eissa LA
    Biol Res; 2024 Jul; 57(1):47. PubMed ID: 39033184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquiritigenin attenuates high glucose-induced mesangial matrix accumulation, oxidative stress, and inflammation by suppression of the NF-κB and NLRP3 inflammasome pathways.
    Zhu X; Shi J; Li H
    Biomed Pharmacother; 2018 Oct; 106():976-982. PubMed ID: 30119269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cepharanthine and Piperine ameliorate diabetic nephropathy in rats: role of NF-κB and NLRP3 inflammasome.
    Samra YA; Said HS; Elsherbiny NM; Liou GI; El-Shishtawy MM; Eissa LA
    Life Sci; 2016 Jul; 157():187-199. PubMed ID: 27266851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin/PAR-1 activation induces endothelial damages via NLRP1 inflammasome in gestational diabetes.
    Liu Y; Tang ZZ; Zhang YM; Kong L; Xiao WF; Ma TF; Liu YW
    Biochem Pharmacol; 2020 May; 175():113849. PubMed ID: 32059841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural swietenine attenuates diabetic nephropathy by regulating the NF-κB/NLRP3/Caspase-1 signaling pathways: In vivo and in vitro study.
    Duan J; He L; Deng W; Lu M; Zhai Y; Pei F; Liu S; Zhang C
    Environ Toxicol; 2022 Dec; 37(12):2977-2989. PubMed ID: 36066211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artesunate ameliorates high glucose-induced rat glomerular mesangial cell injury by suppressing the TLR4/NF-κB/NLRP3 inflammasome pathway.
    Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J
    Chem Biol Interact; 2018 Sep; 293():11-19. PubMed ID: 30031708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calycosin modulates NLRP3 and TXNIP-mediated pyroptotic signaling and attenuates diabetic nephropathy progression in diabetic rats; An insight.
    Yosri H; El-Kashef DH; El-Sherbiny M; Said E; Salem HA
    Biomed Pharmacother; 2022 Nov; 155():113758. PubMed ID: 36271546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
    Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zhen-wu-tang ameliorates membranous nephropathy rats through inhibiting NF-κB pathway and NLRP3 inflammasome.
    Liu B; Lu R; Li H; Zhou Y; Zhang P; Bai L; Chen D; Chen J; Li J; Yu P; Wu J; Liang C; Song J; Liu X; Zhou J
    Phytomedicine; 2019 Jun; 59():152913. PubMed ID: 30991182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus.
    Wang Y; Yu B; Wang L; Yang M; Xia Z; Wei W; Zhang F; Yuan X
    PLoS One; 2017; 12(7):e0181248. PubMed ID: 28708885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coptidis Rhizoma inhibits NLRP3 inflammasome activation and alleviates renal damage in early obesity-related glomerulopathy.
    Ren Y; Wang D; Lu F; Zou X; Xu L; Wang K; Huang W; Su H; Zhang C; Gao Y; Dong H
    Phytomedicine; 2018 Oct; 49():52-65. PubMed ID: 30217262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy.
    Du L; Wang J; Chen Y; Li X; Wang L; Li Y; Jin X; Gu X; Hao M; Zhu X; Yin X; Lu Q
    Cell Biol Toxicol; 2020 Jun; 36(3):243-260. PubMed ID: 31768838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation.
    Wang S; Li Y; Fan J; Zhang X; Luan J; Bian Q; Ding T; Wang Y; Wang Z; Song P; Cui D; Mei X; Ju D
    Cell Death Dis; 2017 Jul; 8(7):e2937. PubMed ID: 28726774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.